Dr. Nimita Limaye provides strategic advisory and market analysis on key topics related to Life Sciences R&D Strategy and Technology, and is IDC's primary life sciences AI analyst. An executive business leader with over three decades of life sciences leadership experience, spanning pharma, CRO, and tech consulting, she has led business strategy and managed large global operations. An extremely well networked thought leader, she has been ranked amongst the top 50 analysts in the AR100 Market Amplifiers Power 100 list in Q4 2025. She was the recipient of the 2024 DIA Global Inspire Award and has served as the past chair of the SCDM board. She is the current chair of the DIA Global Medical Writing community.

Bindu Narang heads the Aggregate Safety, Signalling and Risk Management Practice at Labcorp Drug Development. A pharmacist by qualification (post grad degree in Medicinal Chemistry) with 19 years supporting biopharma regulatory medical writing and 10 years in medical affairs/ marketing roles, Bindu has significant leadership experience, set-up regulatory, medical communications and regulatory operations; managed teams in Labelling, Medical Information, Aggregate Safety, Signal and Risk Management. Among key accomplishments, there’s setting up of a global medical writing team for Pfizer Global R&D’s Development Operations in 2004, and growing a Safety and Medical Writing practise for Sciformix in 2012.

Anuprita Sheth is a senior life sciences leader with 25+ years of global experience across pharma, biotech, and CROs. She specializes in strategic outsourcing, vendor management, and performance analytics across the drug development lifecycle. Currently, she leads global vendor oversight for R&D and medical safety, managing a multi-million-dollar portfolio across APAC, EMEA, and the Americas. She has held leadership roles at Amgen, BMS, Cognizant, and Pfizer, and pioneered Amgen’s vendor liaison model. Anuprita holds a Master’s in Statistics, a PG Diploma in Business Management, and a Strategic Management credential from IIM Ahmedabad. She is also a recognized speaker and mentor in the industry.

Dr. Rajesh is a Physician (MD) by qualification with MBA in Healthcare & has around 25 years of industry experience in Medical Writing & Medical Affairs. He brings rich medical writing experience throughout product life cycle spanning across Regulatory Writing, Clinical Trial Disclosures, Safety writing, Scientific Communications and digital content writing. He has expertise in building strategic Medical writing partnerships for various global pharma’s, and contribute to development of innovative technology solutions for Medical writing domain. He is currently working as Head of Medical Writing and Medical Affairs at Tata consultancy Services and is based out of Mumbai. He is happily married and blessed with two lovely daughters.

Mark's law practice at Ropes & Gray focuses on human and animal research, stem cell and genetic research, research grants and contracts, research fraud, and international research. Mark formerly served at Harvard as the Senior Associate Provost for Research, and in 2004 started and directed for several years Harvard's HIV/AIDS treatment programs in Nigeria, Tanzania and Botswana. He has served as chief administrative officer at St. Jude Children’s Research Hospital, and has held senior appointed positions in the New York City and State departments of health. Mark is co-chair of the Subcommittee on Harmonization of Research Regulations, HHS Secretary’s Advisory Committee on Human Subjects Protections.

Dr. Preeti Verma is an MS in OBG with over 15 years of experience in Medicine and PVG. She is Head of Operations and Delivery,drug safety, MICC and regulatory affairs.Prior, to this, she was she Associate Vice President, Pharmacovigilance Operations at APCER.She has experience in ICSR processing/Signal Management/Aggregate Report/quality management/handling audits&inspections exhibiting rapid progression for excellence,process implementation/improvements/transition and driving innovation. In her corporate career, she has been associated with various therapeutic areas as Dermatology,Endocrinology,Neurology&Respiratory diseases.

Dr. Bobby George is Vice President & Group Head of Regulatory Affairs at Reliance Life Sciences, Mumbai. He holds Masters and Ph.D. in Pharmacology from Panjab University, Chandigarh. He has also completed Senior Management Program from IIM, Kozhikode. He has over 25 years of industrial experience. He has been with Reliance Life Sciences for over 2 decades now. At Reliance, he is responsible for all their regulatory services across Pharmaceuticals, Biosimilars, Blood products and Vaccines in both domestic and export markets. He has to his credit several publications including a book which he authored on healthcare laws and reforms called “The Act that Wasn’t”.